Stay updated on APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial
Sign up to get notified when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.

Latest updates to the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer revision/build indicator has been updated from v3.5.2 to v3.5.3, indicating a platform/version release. No study-related fields or record content changes are shown.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision history updated: added v3.5.2 and removed v3.5.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedRevision v3.5.0 was added to the history and v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the record history.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and older notices about funding and the previous revision (v3.4.1) were removed.SummaryDifference0.7%

- Check82 days agoChange DetectedRecord History shows a new site-wide notice about government funding and an updated Revision: v3.4.1, with the previous Revision: v3.4.0 removed. These maintenance updates do not affect trial content, data, or user-facing study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APR-246+Azacitidine Post-AlloSCT in TP53 Mut AML/MDS Clinical Trial page.